SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (3181)6/3/1999 3:40:00 PM
From: Vector1  Read Replies (3) of 10280
 
<<3.FDA letters-very common.Start high and come down.Very common but ususaly not published on
wires. >>

The shorts are after SEPR big time. No big deal but will cause substantial price swings. ML also came out with a positive report today.

If Xen has the same (or better) effacacy as Albuterol but a lower incidence of side effects it should eventually dominate the market. Has SEPR done any deals with company's like Inhale or Dura that have metered dose inhaler technology.

V1
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News